Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 281 | ERAS | ERASCA INC | Healthcare | 73,896.0 | $275K | 0.07% | NEW | — | $3.72 | +176.1% |
| 282 | LQDA | LIQUIDIA CORPORATION | Healthcare | 7,969.0 | $275K | 0.07% | NEW | — | $34.49 | +65.2% |
| 283 | JBIO | JADE BIOSCIENCES INC | Healthcare | 17,759.0 | $274K | 0.07% | NEW | — | $15.43 | +42.6% |
| 284 | WVE | WAVE LIFE SCIENCES LTD | Healthcare | 16,064.0 | $273K | 0.07% | NEW | — | $17.00 | -62.4% |
| 285 | CMPS | COMPASS PATHWAYS PLC | Healthcare | 39,471.0 | $272K | 0.07% | NEW | — | $6.90 | +53.0% |
| 286 | ABUS | ARBUTUS BIOPHARMA CORP | Healthcare | 56,483.0 | $272K | 0.07% | NEW | — | $4.81 | -12.7% |
| 287 | XENE | XENON PHARMACEUTICALS INC | Healthcare | 6,037.0 | $271K | 0.07% | NEW | — | $44.82 | +19.8% |
| 288 | VERA | VERA THERAPEUTICS INC | Healthcare | 5,342.0 | $271K | 0.07% | NEW | — | $50.64 | -32.2% |
| 289 | CTMX | CYTOMX THERAPEUTICS INC | Healthcare | 63,491.0 | $270K | 0.07% | NEW | — | $4.26 | -17.8% |
| 290 | LXEO | LEXEO THERAPEUTICS INC | Healthcare | 27,230.0 | $270K | 0.07% | NEW | — | $9.93 | -52.6% |
| 291 | IDYA | IDEAYA BIOSCIENCES INC | Healthcare | 7,819.0 | $270K | 0.07% | NEW | — | $34.57 | -18.1% |
| 292 | DYN | DYNE THERAPEUTICS INC | Healthcare | 13,806.0 | $270K | 0.07% | NEW | — | $19.56 | -15.4% |
| 293 | CYTK | CYTOKINETICS INC | Healthcare | 4,247.0 | $270K | 0.07% | NEW | — | $63.54 | +18.3% |
| 294 | CGON | CG ONCOLOGY INC | Healthcare | 6,497.0 | $270K | 0.07% | NEW | — | $41.52 | +52.5% |
| 295 | PROK | PROKIDNEY CORP | Healthcare | 120,376.0 | $270K | 0.07% | NEW | — | $2.24 | -28.1% |
| 296 | BEAM | BEAM THERAPEUTICS INC | Healthcare | 9,724.0 | $270K | 0.07% | NEW | — | $27.72 | -5.0% |
| 297 | ANNX | ANNEXON INC | Healthcare | 53,527.0 | $269K | 0.07% | NEW | — | $5.02 | -2.2% |
| 298 | RVMD | REVOLUTION MEDICINES INC | Healthcare | 3,371.0 | $268K | 0.07% | NEW | — | $79.65 | +81.3% |
| 299 | ORKA | ORUKA THERAPEUTICS INC | Healthcare | 8,814.0 | $267K | 0.07% | NEW | — | $30.31 | +92.5% |
| 300 | RAPP | RAPPORT THERAPEUTICS INC | Healthcare | 8,789.0 | $267K | 0.07% | NEW | — | $30.34 | +16.0% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
25.9%
Financial Services
25.7%
Technology
17.4%
Industrials
10.0%
Consumer Cyclical
7.5%
Communication Services
4.3%
Energy
2.6%
Real Estate
2.5%
Consumer Defensive
1.8%
Basic Materials
1.5%